<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03571490</url>
  </required_header>
  <id_info>
    <org_study_id>V2.02.05.2017</org_study_id>
    <secondary_id>2017-002130-23</secondary_id>
    <nct_id>NCT03571490</nct_id>
  </id_info>
  <brief_title>Ultrasound-guided Transmuscular Quadratus Lumborum Block for Elective Laparoscopic Hand-assisted Nephrectomy and Robot Assisted Partiel Nephrectomy</brief_title>
  <official_title>Improving Postoperative Pain Management With the Ultrasound-guided Transmuscular Quadratus Lumborum Block for Elective Laparoscopic Hand-assisted Nephrectomy and Robot-assisted Partiel Nephrectomy: A Double Blind, Randomized, Placebo Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zealand University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zealand University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients with kidney cancer often undergo hand-assisted laparoscopic nephrectomy or Robot
      assisted partiel nephrectomy. The investigators performed a one-year retrospective study. the
      sudy revealed that 67% of the patients needed substantial amounts of opioids for
      postoperative pain management (PPM) in recovery despite a multimodal analgesic regime. In a
      prospective pilot study including ten laparoscopic hand-assisted nephrectomy, with severe
      postoperative pain the investigators found that bilateral Ultrasound-guided (USG)
      transmuscular quadratus lumborum (TQL) block substantially reduced pain and opioid
      consumption. This study aims to evaluate the effect on PPM of a bilateral USG TQL block
      compared to placebo.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 26, 2018</start_date>
  <completion_date type="Actual">June 24, 2019</completion_date>
  <primary_completion_date type="Actual">June 24, 2019</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Double blind placebo Controlled Trial</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
    <masking_description>Double blind</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>opioid consumption</measure>
    <time_frame>12 hours postoperatively</time_frame>
    <description>Opioid consumption postoperatively: data from Patient Controlled Analgesia(PCA) pump and patient medical record).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>opioid consumption</measure>
    <time_frame>6 hours postoperatively</time_frame>
    <description>Opioid consumption postoperatively (data from PCA pump and patient medical record).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>opioid consumption</measure>
    <time_frame>18 hours postoperatively</time_frame>
    <description>Opioid consumption postoperatively (data from PCA pump and patient medical record).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>opioid consumption</measure>
    <time_frame>24 hours postoperatively</time_frame>
    <description>Opioid consumption postoperatively (data from PCA pump and patient medical record).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>NRS score</measure>
    <time_frame>12 hours postoperatively</time_frame>
    <description>Numeric Rating Scale(NRS). Scores range from 0-10, 0=no pain-10=worst pain postoperatively at rest and activity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>NRS score at rest and activity</measure>
    <time_frame>6 hours postoperatively</time_frame>
    <description>Numeric Rating Scale(NRS). Scores range from 0-10, 0=no pain-10=worst pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>NRS score at rest and activity</measure>
    <time_frame>18 hours postoperatively</time_frame>
    <description>Numeric Rating Scale(NRS). Scores range from 0-10, 0=no pain-10=worst pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>NRS score at rest and activity</measure>
    <time_frame>24 hours postoperatively</time_frame>
    <description>Numeric Rating Scale(NRS). Scores range from 0-10, 0=no pain-10=worst pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Opioid-related side effects</measure>
    <time_frame>6 hours postoperatively</time_frame>
    <description>The degree of morphine-related side effects (PONV, itching, fatigue, etc.)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Opioid-related side effects</measure>
    <time_frame>12 hours postoperatively</time_frame>
    <description>The degree of morphine-related side effects (PONV, itching, fatigue, etc.)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Opioid-related side effects</measure>
    <time_frame>18 hours postoperatively</time_frame>
    <description>The degree of morphine-related side effects (PONV, itching, fatigue, etc.)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Opioid-related side effects</measure>
    <time_frame>24 hours postoperatively</time_frame>
    <description>The degree of morphine-related side effects (PONV, itching, fatigue, etc.)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction with application of the block. NRS</measure>
    <time_frame>Immediately after application of the block</time_frame>
    <description>Numeric Rating Scale(NRS). Scores range from 0-10, 0=no pain-10=worst pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ambulation</measure>
    <time_frame>within 24 hours postoperatively</time_frame>
    <description>Time from operation to ambulation</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Postoperative Pain</condition>
  <condition>Ultrasound Guided Transmuscular Quadratus Lumborum Block</condition>
  <arm_group>
    <arm_group_label>TQL Ropivacaine(active)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Bilateral Single shot of ropivacaine 0.325% 30 mL. In total 60 mL of 0.325% ropivacaine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TQL saline (placebo)</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Bilateral single shot of saline 0.9% 30 mL. in Total 60 mL of saline 0.9%</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine</intervention_name>
    <description>Single shot of ropivacaine 0.325%</description>
    <arm_group_label>TQL Ropivacaine(active)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Saline</intervention_name>
    <description>Single shot of saline 0.9%</description>
    <arm_group_label>TQL saline (placebo)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  over 18 years

          -  Kidney cancer

          -  Have received thorough information, orally and in written

          -  Signed the &quot;Informed Consent&quot; form on participation in the trial

        Exclusion Criteria:

          -  Inability to cooperate

          -  Inability to speak and understand Danish both orally and written

          -  Allergy to local anaesthetics or opioids

          -  Daily intake of opioids

          -  Local infection at the site of injection or systemic infection

          -  Difficulty visualisation of muscular and fascial structures in ultrasound
             visualisation necessary to the block administration

          -  Known abuse of alcohol or medicine

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Zealand university Hospital, Anaesthesiology</name>
      <address>
        <city>Roskilde</city>
        <zip>4000</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>October 27, 2017</study_first_submitted>
  <study_first_submitted_qc>June 26, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 27, 2018</study_first_posted>
  <last_update_submitted>March 18, 2020</last_update_submitted>
  <last_update_submitted_qc>March 18, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 19, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

